DBPR-108
- Generic Name
- DBPR-108
A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM
Phase 3
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2020-01-06
- Last Posted Date
- 2021-06-28
- Lead Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Target Recruit Count
- 214
- Registration Number
- NCT04218734
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
A Multiple Ascending Dose Phase I Study of DBPR108 in Healthy Male Subjects
- First Posted Date
- 2014-06-13
- Last Posted Date
- 2016-03-28
- Lead Sponsor
- National Health Research Institutes, Taiwan
- Target Recruit Count
- 32
- Registration Number
- NCT02163278
- Locations
- 🇨🇳
Taipei Medical University - Taipei Medical University Hospital, Taipei, Taiwan
A Single-dose Phase 1 Study of DBPR108 in Healthy Male Subjects
- First Posted Date
- 2012-07-26
- Last Posted Date
- 2014-08-28
- Lead Sponsor
- National Health Research Institutes, Taiwan
- Target Recruit Count
- 32
- Registration Number
- NCT01650324
- Locations
- 🇨🇳
Taipei Medical University - Wanfang Hospital, Taipei, Taiwan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath